SCHEMBL1587639

SCHEMBL1587639

NNC(=O)c1ccc(C(=O)NCc2ccco2)s1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.72
ALDH1A1 P00352 6/20 0.72
HSD17B10 Q99714 3/20 0.63
HTT P42858 3/20 0.63
TSHR P16473 1/20 0.63
POLB P06746 7/20 0.59
MAPT P10636 3/20 0.59
TDP1 Q9NUW8 3/20 0.59
KDM4E B2RXH2 2/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
ESR1 P03372 1/20 0.59
MAPK1 P28482 1/20 0.59
ESR2 Q92731 1/20 0.59
SMN1; SMN2 Q16637 3/20 0.55
NPC1 O15118 1/20 0.55
TP53 P04637 1/20 0.55
RAB9A P51151 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8573184 0.90 HPGD (0.60) HPGDALDH1A1HSD17B10HTTTSHR
SCHEMBL1587763 0.85 ALDH1A1 (0.67) HPGDALDH1A1HSD17B10HTTTSHR
SCHEMBL12124265 0.84 ALDH1A1 (0.71) HPGDALDH1A1HSD17B10HTTTSHR
SCHEMBL12313818 0.83 HPGD (0.69) HPGDALDH1A1HSD17B10HTTTSHR
SCHEMBL15259140 0.81 HPGD (0.59) HPGDALDH1A1HSD17B10HTTTSHR
SCHEMBL12265887 0.81 ALDH1A1 (0.66) HPGDALDH1A1HSD17B10HTTTSHR
SCHEMBL31556343 0.78 EPHX2 (0.68) HPGDALDH1A1HSD17B10HTTTSHR
SCHEMBL8573181 0.77 TDP1 (0.57) HPGDALDH1A1HSD17B10HTTPOLB
SCHEMBL1455280 0.76 ALDH1A1 (0.64) HPGDALDH1A1HSD17B10HTTTSHR
SCHEMBL1588087 0.75 HPGD (0.43) HPGDALDH1A1TSHRPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968542-B2 Thiophene compounds and thrombopoietin receptor activators NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-06-28 US disclosed
US-7968542-B2 Thiophene compounds and thrombopoietin receptor activators NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-06-28 US disclosed
US-20110092496-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-04-21 US disclosed
US-20110092496-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-04-21 US disclosed
US-20090118500-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD (JP) 2009-05-07 US disclosed
US-20090118500-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD (JP) 2009-05-07 US disclosed
WO-2007010954-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118500-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS TEK, MPL, THPO HPGD 2277/4885ALDH1A1 2481/4885HSD17B10 4151/4885
US-20110092496-A1 THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS TEK, MPL, THPO HPGD 2277/4885ALDH1A1 2481/4885HSD17B10 4151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.